Comparisons of Serum Infliximab and Antibodies-to-Infliximab Tests Used in Inflammatory Bowel Disease Clinical Trials of Remicade®

Published 2016 View Full Article

Authors

Keywords

antibodies-to-infliximab, electrochemiluminescence immunoassay (ECLIA), enzyme-linked immunosorbent assay (ELISA), inflammatory bowel disease, infliximab

Journal

AAPS Journal

Volume 19, Issue 1, Pages 161-171

Publisher

American Association of Pharmaceutical Scientists (AAPS)

Online

2016-09-07

DOI

10.1208/s12248-016-9981-3

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Reprint

Contact the author

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started